• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌发生机制:通向胆管癌的多阶段致病级联反应

Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma.

作者信息

Holzinger F, Z'graggen K, Büchler M W

机构信息

Department of Visceral and Transplantation Surgery, Inselspital, University of Berne, Switzerland.

出版信息

Ann Oncol. 1999;10 Suppl 4:122-6.

PMID:10436802
Abstract

Carcinomas of the biliary tract are rare cancers developing from the epithelial or blast-like cells lining the bile ducts. A variety of known predisposing factors and recent experimental models of biliary carcinogenesis (e.g., infection with the liver fluke Opisthorchis viverrini, models of chemically induced carcinogenesis and experimental models of pancreaticobiliary maljunction) have elucidated different stages of this complex system of biliary tumorigenesis. Chronic inflammatory processes, generation of active oxygen radicals, altered cellular detoxification mechanisms, activation of oncogenes, functional loss of tumor-suppressor genes and dysregulation of cell proliferation and cell apoptotic mechanisms have been identified as important contributors in the development of cholangiocarcinomas. In this review, the known mechanisms involved in the carcinogenesis of biliary epithelium are addressed. We will divide the topic into four stages: 1) Predisposition and risk factors of biliary cancer. 2) Genotoxic events and alterations leading to specific DNA damage and mutation patterns. 3) Dysregulation of DNA repair mechanisms and apoptosis, permitting survival of mutated cells and 4) Morphological evolution from premalignant biliary lesions to cholangiocarcinoma. Finally, established and hypothetical future therapeutic strategies directed towards specific pathogenetic events during biliary carcinogenesis will be addressed.

摘要

胆管癌是一种罕见的癌症,由胆管内衬的上皮细胞或原始样细胞发展而来。多种已知的诱发因素以及最近的胆管癌发生实验模型(例如,感染肝吸虫华支睾吸虫、化学诱导致癌模型和胰胆管连接异常实验模型)已经阐明了这个复杂的胆管肿瘤发生系统的不同阶段。慢性炎症过程、活性氧自由基的产生、细胞解毒机制的改变、癌基因的激活、肿瘤抑制基因的功能丧失以及细胞增殖和细胞凋亡机制的失调已被确定为胆管癌发生发展的重要因素。在这篇综述中,我们将探讨胆管上皮癌变的已知机制。我们将这个主题分为四个阶段:1)胆管癌的易感性和危险因素。2)导致特定DNA损伤和突变模式的基因毒性事件和改变。3)DNA修复机制和细胞凋亡的失调,使突变细胞得以存活,以及4)从癌前胆管病变到胆管癌的形态学演变。最后,我们将探讨针对胆管癌发生过程中特定致病事件的既定和假设性未来治疗策略。

相似文献

1
Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma.胆管癌发生机制:通向胆管癌的多阶段致病级联反应
Ann Oncol. 1999;10 Suppl 4:122-6.
2
Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.胆管癌:流行病学、致癌机制与预防
Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):537-44.
3
Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.原发性硬化性胆管炎中的肝胆及肝外恶性肿瘤
Best Pract Res Clin Gastroenterol. 2001 Aug;15(4):643-56. doi: 10.1053/bega.2001.0210.
4
[Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].[原发性硬化性胆管炎中的胆管癌:“一场事先张扬的死亡纪事”?]
Harefuah. 2003 Jun;142(6):421-5, 486.
5
Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.胆管癌癌前病变及早期癌病变的组织学特征。
J Hepatobiliary Pancreat Sci. 2014 Jul;21(7):448-52. doi: 10.1002/jhbp.71. Epub 2014 Jan 21.
6
Role of epigenetic alterations in cholangiocarcinoma.表观遗传改变在胆管癌中的作用。
J Hepatobiliary Pancreat Surg. 2006;13(4):274-9. doi: 10.1007/s00534-005-1055-3.
7
Diagnosis and management of cholangiocarcinomas: a comprehensive review.胆管癌的诊断与管理:全面综述
Hepatogastroenterology. 2004 Jan-Feb;51(55):43-50.
8
High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation.先天性胆管扩张症初次切除术后胆管癌变风险高。
Oncol Rep. 2003 Sep-Oct;10(5):1183-7.
9
Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand.泰国肝吸虫相关性胆管癌的多阶段致癌作用
Princess Takamatsu Symp. 1991;22:77-86.
10
Cholangiocarcinoma.胆管癌
Nat Clin Pract Gastroenterol Hepatol. 2006 Jan;3(1):33-42. doi: 10.1038/ncpgasthep0389.

引用本文的文献

1
Choledocholithiasis as a risk factor for cholangiocarcinoma: a nationwide retrospective cohort study.胆总管结石作为胆管癌的危险因素:一项全国性回顾性队列研究。
BMC Gastroenterol. 2025 Mar 5;25(1):138. doi: 10.1186/s12876-025-03746-w.
2
Dynamic insights: prenatal ultrasound diagnosis and evolutionary patterns of bile duct hamartoma.动态见解:胆管错构瘤的产前超声诊断及演变模式
Quant Imaging Med Surg. 2024 Oct 1;14(10):7723-7727. doi: 10.21037/qims-23-1788. Epub 2024 Sep 26.
3
Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids.
通过对患者来源的胆管囊腺瘤肝类器官进行 RNA 测序,鉴定出与胆管囊腺瘤相关的基因 FGFR2 和 CEBPB。
PLoS One. 2023 Mar 30;18(3):e0283737. doi: 10.1371/journal.pone.0283737. eCollection 2023.
4
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis.原发性硬化性胆管炎向胆管癌肿瘤级联过程中的遗传改变。
J Pathol. 2022 Nov;258(3):227-235. doi: 10.1002/path.5994. Epub 2022 Sep 6.
5
Imaging analysis of the malignant transformation of bile duct hamartomas in the liver: A case report and literature review.肝脏胆管错构瘤恶变的影像学分析:1例报告及文献复习
Exp Ther Med. 2022 Jun;23(6):431. doi: 10.3892/etm.2022.11358. Epub 2022 May 9.
6
Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma.吡喹酮介导预防胆管癌细胞转化的代谢组学分析:胆管癌细胞癌的仓鼠模型。
Cancer Genomics Proteomics. 2021 Jan-Feb;18(1):29-42. doi: 10.21873/cgp.20239.
7
Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.东南亚的华支睾吸虫病与胆管癌:一个尚未解决的问题。
Int J Gen Med. 2017 Aug 10;10:227-237. doi: 10.2147/IJGM.S133292. eCollection 2017.
8
Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.幽门螺杆菌属感染与肝胆恶性肿瘤之间的关联:一项综述
World J Gastroenterol. 2015 Feb 7;21(5):1414-23. doi: 10.3748/wjg.v21.i5.1414.
9
Can thymidine phosphorylase be a predictive marker for gemcitabine and doxifluridine combination chemotherapy in cholangiocarcinoma?: case series.胸苷磷酸化酶能否作为吉西他滨与多西氟尿苷联合化疗治疗胆管癌的预测标志物?:病例系列
Medicine (Baltimore). 2014 Dec;93(28):e305. doi: 10.1097/MD.0000000000000305.
10
Diagnosis of distal cholangiocarcinoma after the removal of choledocholithiasis.胆总管结石取石术后诊断为远端胆管癌。
Gastroenterol Res Pract. 2012;2012:396869. doi: 10.1155/2012/396869. Epub 2012 Nov 22.